News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Kendle International (KNDL) to Share Insights at Upcoming Drug Information Association EuroMeeting and Cambridge Healthtech Institute Summit for Clinical Ops Executives

3/8/2010 11:10:33 AM

CINCINNATI, March 8 /PRNewswire-FirstCall/ -- Kendle , a leading, global full-service clinical research organization, today announced several of its executives will present on key industry issues at the Drug Information Association (DIA) 22nd Annual EuroMeeting March 8-10, 2010, in Monaco, as well as at the Cambridge Healthtech Institute's Summit for Clinical Ops Executives (SCOPE) Conference, also March 8-10 in Philadelphia. Kendle experts will address key topics in clinical development including adaptive trial design, interim analysis, electronic adjudication and clinical research in Latin America.

Dr. Sietsema is a global thought leader on clinical development planning. He is an accomplished author - the most recent of his four books is Preparation and Maintenance of the IND Application in eCTD Format - as well as speaker and has presented at more than 50 professional conferences around the world. In 2007 he was named one of the "Notable People in R&D" by industry publication R&D Directions.

Kendle Speakers at SCOPE

Dr. Hurley is one of the preeminent experts on clinical development in Latin America. He has more than three decades of experience in the region and has spoken around the world on the benefits and nuances of conducting trials in Latin America.

Kendle International Inc. is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Kendle International Inc.

Read at

Related News

comments powered by Disqus